CIBC Asset Management’s Third Harmonic Bio THRD Stock Holding History
Bought
Maintained
Sold
Other funds holding THRD
AVLSA
O
BI
EC
GA
RCM
BC
CC
CIBC Asset Management's THRD Position: Q2 2024 in Review
CIBC Asset Management sold out of Third Harmonic Bio (THRD) in Q2 2024, closing a stake of 10,573 shares — an estimated $99.8K sold.
CIBC Asset Management first reported a position in THRD in Q1 2023 and held it in 5 quarters. The position peaked at $116K in Q4 2023. 76 funds tracked by Wall St. Rank hold THRD as of Q2 2024.
- CIBC Asset Management reported no remaining Third Harmonic Bio position as of Q2 2024 after selling out during the quarter.
- CIBC Asset Management sold 10,573 Third Harmonic Bio shares in Q2 2024, an estimated $99.8K.
- CIBC Asset Management first reported a position in Third Harmonic Bio in Q1 2023 and held it in 5 quarters.
- CIBC Asset Management's Third Harmonic Bio position peaked at $116K in Q4 2023.
- 76 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2024.
Based on CIBC Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.